Skip to main content
OpenTrials

Clinical trial condition

Stage II Breast Cancer AJCC v6 and v7

Explore clinical trials studying Stage II Breast Cancer AJCC v6 and v7. Study availability and eligibility vary by location and protocol.

25 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Stage II Breast Cancer AJCC v6 and v7 trial results

Active, Not Recruiting

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

NCT02954874

Conditions
Breast Carcinoma In Situ, Breast Carcinoma in Situ, Breast Diseases, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Southern Cancer Center PC-Daphne Daphne, Alabama, United States
  • Southern Cancer Center PC-Mobile Mobile, Alabama, United States
  • Southern Cancer Center PC-Providence Mobile, Alabama, United States
View all 919 locations
View Trial Details
Active, Not Recruiting

Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer

NCT02912312

Conditions
Breast Diseases, Breast Neoplasms, Invasive Breast Carcinoma, +12 more
Locations
  • MD Anderson Cancer Center (Banner) Gilbert, Arizona, United States
  • Scripps- MD Anderson Cancer San Diego, California, United States
  • MD Anderson Cancer Center (Banner)- Northern Colorado Greeley, Colorado, United States
  • Baptist - MD Anderson Cancer Center Jacksonville, Florida, United States
View Trial Details
Active, Not Recruiting

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

NCT02276443

Conditions
Breast Diseases, Breast Neoplasms, Invasive Breast Carcinoma, +16 more
Locations
  • MD Anderson in The Woodlands Conroe, Texas, United States
  • M D Anderson Cancer Center Houston, Texas, United States
  • MD Anderson West Houston Houston, Texas, United States
  • MD Anderson League City League City, Texas, United States
View Trial Details
Active, Not Recruiting

Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer

NCT03012100

Conditions
Bilateral Breast Carcinoma, Breast Diseases, Breast Inflammatory Carcinoma, +18 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
View Trial Details

Related conditions